IHS Chemical Week

Regions :: Western Europe :: Netherlands

Crucell and DSM Hit Pharmaceutical Technology Milestone

10:24 AM MDT | June 16, 2008 | Alex Scott

Percivia, a biotech research business jointly owned by biotech firm Crucell (Leiden, the Netherlands) and DSM, says it has significantly raised the yield of its mammalian cell-based technology for producing therapeutic proteins. From the latest test results Percivia says its PER.C6 human cell line, in conjunction with XD Technology generated a record yield of more than 27 grams/liter of therapeutic proteins. The increase compares with a yield in March of this year of just 15 grams/liter. This milstone was achieved using standard bioreactor equipment and readily...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa